A health-economic evaluation of disease-modifying drugs for the treatment of relapsing-remitting multiple sclerosis from the German societal perspective.

Source:http://linkedlifedata.com/resource/pubmed/id/20435242

Download in:

View as

General Info

PMID
20435242